why choose us

First received: November 02, 2023

Clinical Trial: A Safety Study of SGN-35T in Adults With Advanced Cancers

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lymphoma, T-Cell, Cutaneous

Study Type: INTERVENTIONAL


Official Title: An Open-label Phase 1 Study to Evaluate the Safety of SGN-35T in Adults With Advanced Malignancies

Brief Summary: This clinical trial is studying lymphoma.Lymphoma is a cancer that starts in the blood cells that fight infections.There are several types of lymphoma.This study will enroll people who have lymphoma, such as classical Hodgkin lymphoma, peripheral T-cell lymphoma including systemic anaplastic large cell lymphoma, diffuse large B-cell lymphoma, or types of primary cutaneous lymphoma.This clinical trial uses a drug called SGN-35T.The study drug is in testing and has not been approved for sale.This is the first time…

Read more